FDA Drug Approvals: Key Trends, Leading Companies and Innovation Hubs
FDA drug approvals serve as the pulse of pharmaceutical innovation. Between 2015 and 2024, the FDA approved 462 new drugs – a 69% increase from the previous decade. However, annual growth has slowed, indicating that investments in drug development are outpacing new approvals.
Download Whitepaper for free
- FDA approvals grew over 20 years, but annual growth has recently slowed.
- Small molecules continue to dominate over biologics.
- U.S., Swiss, and UK companies lead in novel drug approvals.
free download
API Market trends with growth, leaders and innovation
Drop your email, and our QYOBO team will reach out to you shortly!
free download
FDA Drug Approvals:
Key Trends, Leading Companies and Innovation Hubs
Drop your email, and our QYOBO team will reach out to you shortly!
By submitting this form, I declare that I have read and understood QYOBO’s privacy policy and give my explicit consent to the processing of my personal data for the stated purposes. I am aware that I can revoke my consent at any time.
